Testing effectiveness (Phase 2)Ended earlyNCT00301795
What this trial is testing
Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
Who this might be right for
Stage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage III Grade 3 Follicular Lymphoma+3 more
National Cancer Institute (NCI) 52